Mgr. Tomáš Loja, Ph.D.
Technology expert, Genomics Core Facility
office: bldg. E35/234
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 7455 |
|---|---|
| e‑mail: |
| social and academic networks: |
|---|
Total number of publications: 116
2024
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
Leukemia, year: 2024, volume: 38, edition: 8, DOI
2023
-
Biomaterial selection does not affect AML engraftment in humanized ossicles.
Year: 2023, type: Conference abstract
-
CCL2/MCP-1, interleukin-8, and fractalkine/CXC3CL1: Potential biomarkers of epileptogenesis and pharmacoresistance in childhood epilepsy
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, year: 2023, volume: 46, edition: September 2023, DOI
-
Coculture model with CD40L, IL4 and IL21 for study chronic lymphocytic leukemia proliferation.
Year: 2023, type: Conference abstract
-
Functional analysis of LDLR variants using flow cytometry
Year: 2023, type: Conference abstract
-
Functional analysis of LDLR variants using flow cytometry and western blot
Year: 2023, type: Appeared in Conference without Proceedings
-
Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation in rituximab-resistant cells.
Year: 2023, type: Conference abstract
-
Genome-wide CRISPR/Cas9 knockout screening revealed genes involved in CD20 regulation.
Year: 2023, type: Conference abstract
-
Characterisation of Macrophage Response to Nickel Nanoparticles and Ions Released from Biomaterials
Year: 2023, type: Conference abstract
-
Identification of novel targets that upregulate CD20 expression in rituximab-resistant cells with the use of genomewide CRISPR screening.
Year: 2023, type: Conference abstract